학술논문

ATAC-Seq Reveals an Isl1 Enhancer That Regulates Sinoatrial Node Development and Function
Document Type
article
Source
Circulation Research. 127(12)
Subject
Biomedical and Clinical Sciences
Cardiovascular Medicine and Haematology
Clinical Sciences
Human Genome
Stem Cell Research - Embryonic - Non-Human
Cardiovascular
Heart Disease
Genetics
Biotechnology
Stem Cell Research
1.1 Normal biological development and functioning
Aetiology
Underpinning research
2.1 Biological and endogenous factors
Action Potentials
Animals
Arrhythmia
Sinus
Biological Clocks
Chromatin Immunoprecipitation Sequencing
Enhancer Elements
Genetic
Epigenesis
Genetic
Female
Gene Expression Regulation
Developmental
Gestational Age
Heart Rate
Humans
LIM-Homeodomain Proteins
Male
Mice
Inbred C57BL
Mice
Transgenic
Polymorphism
Single Nucleotide
Sinoatrial Node
Time Factors
Transcription Factors
Zebrafish
chromatin
heart rate
mice
sinoatrial node
zebrafish
Cardiorespiratory Medicine and Haematology
Cardiovascular System & Hematology
Cardiovascular medicine and haematology
Clinical sciences
Language
Abstract
RationaleCardiac pacemaker cells (PCs) in the sinoatrial node (SAN) have a distinct gene expression program that allows them to fire automatically and initiate the heartbeat. Although critical SAN transcription factors, including Isl1 (Islet-1), Tbx3 (T-box transcription factor 3), and Shox2 (short-stature homeobox protein 2), have been identified, the cis-regulatory architecture that governs PC-specific gene expression is not understood, and discrete enhancers required for gene regulation in the SAN have not been identified.ObjectiveTo define the epigenetic profile of PCs using comparative ATAC-seq (assay for transposase-accessible chromatin with sequencing) and to identify novel enhancers involved in SAN gene regulation, development, and function.Methods and resultsWe used ATAC-seq on sorted neonatal mouse SAN to compare regions of accessible chromatin in PCs and right atrial cardiomyocytes. PC-enriched assay for transposase-accessible chromatin peaks, representing candidate SAN regulatory elements, were located near established SAN genes and were enriched for distinct sets of TF (transcription factor) binding sites. Among several novel SAN enhancers that were experimentally validated using transgenic mice, we identified a 2.9-kb regulatory element at the Isl1 locus that was active specifically in the cardiac inflow at embryonic day 8.5 and throughout later SAN development and maturation. Deletion of this enhancer from the genome of mice resulted in SAN hypoplasia and sinus arrhythmias. The mouse SAN enhancer also directed reporter activity to the inflow tract in developing zebrafish hearts, demonstrating deep conservation of its upstream regulatory network. Finally, single nucleotide polymorphisms in the human genome that occur near the region syntenic to the mouse enhancer exhibit significant associations with resting heart rate in human populations.Conclusions(1) PCs have distinct regions of accessible chromatin that correlate with their gene expression profile and contain novel SAN enhancers, (2) cis-regulation of Isl1 specifically in the SAN depends upon a conserved SAN enhancer that regulates PC development and SAN function, and (3) a corresponding human ISL1 enhancer may regulate human SAN function.